SANTA CLARA (AP) - Intel CEO Paul Otellini is retiring in May, giving the world's largest maker of microprocessors six months to find a new leader as it confronts two major challenges: a shaky economy and a shift toward mobile devices that is reducing demand for its PC chips.
LOS ANGELES (AP) - Five of the biggest U.S. banks have cut struggling homeowners' mortgage balances by $6.3 billion, part of a total $26.1 billion in home loan relief provided under a landmark settlement over foreclosure abuses.
LOS ANGELES (AP) - Americans cranked up their use of credit cards in the third quarter, racking up more debt than a year ago, while also being less diligent about making payments on time, an analysis of consumer-credit data shows.
NEW YORK (AP) - J.C. Penney CEO Ron Johnson seems unfazed that the department store chain's mounting losses and sales declines have led to growing criticism of his plan to change the way we shop. Perhaps that's because this isn't the first time during Johnson's 30-year career that he's attempted what seemed impossible.
LOS ANGELES (AP) - California continued its economic recovery as the unemployment rate dipped to 10.1 percent in October, led by increases in private sector jobs such as construction, retail and well-paying professional work.
SAN JOSE (AP) - A California registered sex offender convicted of molesting a relative was caught volunteering at a Catholic elementary school festival, but he was not arrested because he had a permission letter from a church official.
OAKLAND (AP) - A federal judge has ordered city officials to negotiate with two lawyers who want the embattled Oakland Police Department to become the first in the nation to be taken over by the federal government.
SAN FRANCISCO (AP) - Did the National Security Agency plant spyware deep in the hard drives of thousands of computers used by foreign governments, banks and other surveillance targets around the world?
WASHINGTON (AP) - The makers of a twice-rejected pill designed to boost sexual desire in women are hoping a yearlong lobbying push by politicians, women's groups and consumer advocates will move their much-debated drug onto the market.